UPC
Universe Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$4.86
+2.32%Margins
Gross margin
35.9%
EBITDA margin
-7.4%
EBIT margin
-11.8%
Net margin
-10.9%
FCF margin
-69.8%
-3.5%
Return on equity
-2.7%
Return on assets
-3.2%
Return on invested capital
0.25x
Asset turnover
-$11.9M
Cash from operations
$5.78
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026